Clinical Infections and Vaccines

CIVClinical Infections and Vaccines (CIV) – formerly part of the Antimicrobial Agents and Infectious Diseases track – will cover a range of important topics relevant to infectious diseases and their impact on human health. The latest information on common healthcare-associated infections, such as Clostridium difficile, pneumonia, and complicated urinary tract infections, will be featured in this track. The science in this track works to bring together angstrom-level discovery and clinical research to reduce the burden of infectious diseases around the globe. 


CIV01: Clinical Studies of Adult Infectious Diseases, including Clinical Trials and Diseases caused by Bacteria, Viruses, Fungi, Prions or Parasites

CIV02: Infection Prevention and Control: Healthcare-associated and Surgical Infections and Clinical Epidemiology

CIV03: Global Health 

CIV04: Transplant Infectious Diseases 

CIV05: Pediatric Infectious Diseases

CIV06: Vaccines and Immunization Science


Hear from Top Speakers

Keith Kaye
University of Michigan
Jeffrey Lipman
Royal Brisbane & Women's Hospital
Elizabeth Miller
Public Health England
Jacques Schrenzel
University of Geneva Hospital

See who else is speaking. SEARCH ALL SPEAKERS IN TRACK.


Attend Innovative Sessions

Advances in Device-related Infection Prevention and Management
June 8, 2018 • 7:30 a.m. – 8:30 a.m. 

Metagenomics for Clinical Infectious Diseases
June 8, 2018 • 1:30 p.m. – 4:00 p.m. 

Update on the Global Threat of Zika Virus 
June 8, 2018 • 1:30 p.m. – 2:15 p.m. 

CMV Resistance: Limited Options but Promising Future
June 9, 2018 • 1:30 p.m. – 4:00 p.m. 


RegisterNow blue